The relentless progression of brain diseases, such as Huntington's disease, necessitates a change in therapeutic strategies, moving beyond symptomatic management towards disease-modifying therapies. Recent advances in transcriptomics have illuminated several promising novel targets. These include impairment of the lysosomal pathway, which, when … Read More

Alzheimer's disease presents a formidable challenge to researchers worldwide, with few effective treatments currently available. The intricate pathophysiology of the disease involves complex interplay between amyloid plaques, tau tangles, neuroinflammation, and synaptic dysfunction. This nuance necessitates a holistic approach to therapeutic dev… Read More